Fresh figures from the country’s top public health body show how widespread cancer has become – and which tumour types now dominate the statistics. The numbers are stark, but they also point to clear risk factors that can still be changed.
Cancer now affects almost every family in Germany
New data from the Robert Koch Institute (RKI), Germany’s federal public health authority, paint a sobering picture. Almost one in two people in the country will develop cancer at some point in their lives.
According to the RKI, 49% of men and 43% of women in Germany can expect a cancer diagnosis over their lifetime.
The lifetime risk does not only concern older people. Cancer is increasingly being detected in people well before retirement age. The RKI reports that by age 65, roughly one in six women and one in seven men will already have heard the words, “You have cancer.”
For 2023 alone, cancer registries recorded around 517,800 new cases nationwide. Of these, about 276,400 were men and 241,400 were women. That means well over half a million people either started treatment, or had to adjust to living with the disease, in a single year.
The four tumour types that drive half of all new cases
Although cancer is a broad term covering many diseases, a handful of tumour types account for a striking share of the burden. RKI data show that just four cancers – prostate, breast, lung, and colorectal – make up roughly half of all new diagnoses in Germany.
Prostate, breast, lung and bowel cancers together account for about 50% of all newly diagnosed cancers in Germany.
Prostate cancer: the most common diagnosis
Prostate cancer sits at the top of the list, with about 79,600 new cases in 2023. It mainly affects older men, but rising life expectancy means more men are living long enough to develop it.
Screening through PSA blood tests and physical examinations remains controversial, yet it also means many tumours are found at earlier stages. Earlier detection often gives doctors more options, from active surveillance for less aggressive disease to surgery or radiotherapy for higher-risk cases.
➡️ Psychology says people who say “please” and “thank you” activate a trust reflex in others
➡️ Lara Croft Is Back With Two Tomb Raider Games, But Something Has Changed… A Lot
➡️ “I work in regulatory documentation and earn $70,100 a year”
Breast cancer: leading cancer in women
Close behind is breast cancer, with around 75,900 diagnoses. It remains the most common cancer among women in Germany.
Mammography screening programmes have expanded over recent years, increasing early-stage detection. Alongside surgery, modern therapies now include targeted drugs and hormone treatments, which have improved outcomes. Still, the numbers show that breast cancer continues to place a heavy emotional and medical burden on women and their families.
Lung cancer: strongly linked to smoking
In third place stands lung cancer, with around 58,300 new cases. This is the tumour type most clearly associated with smoking, although non-smokers can also be affected.
Changes in smoking behaviour over the past decades are now visible in the statistics. Male lung cancer rates have started to stabilise or decline in some age groups, while female rates in several countries, including Germany, have risen or remained stubbornly high as women’s smoking patterns caught up with men’s.
Colorectal cancer: a largely preventable disease
Colorectal cancer, including tumours of the colon and rectum, accounts for roughly 55,300 cases. This form of cancer often develops slowly from precancerous polyps, which can be spotted and removed during colonoscopy.
That makes bowel cancer one of the more preventable major tumour types – at least in theory. In practice, uptake of screening colonoscopies still leaves gaps, especially among people who feel healthy and avoid check-ups.
Deaths and long-term impact
Beyond diagnoses, cancer remains one of the leading causes of death in Germany. In 2023, around 229,000 people died from cancer, according to the national cause-of-death statistics.
- Approximate total cancer deaths: 229,000
- Men: around 123,000 deaths
- Women: around 106,000 deaths
This makes cancer the second most common cause of death, behind cardiovascular diseases such as heart attacks and strokes. While mortality has improved for some cancers thanks to better therapies, the disease still cuts many lives short and leaves deep scars on patients, relatives and health services.
Risk factors: how lifestyle shapes cancer odds
The raw numbers can seem overwhelming. Yet a significant share of cancers do not simply “happen” by chance. Research suggests that many cases are linked to lifestyle and environmental factors that can be changed.
Experts from Germany’s Cancer Research Center estimate that at least one in three cancer cases could be avoided by reducing key risk factors.
The most influential risks highlighted by current studies include:
- Smoking: still the single biggest avoidable cause of cancer, especially lung, throat and bladder cancers.
- Alcohol: increases the risk of cancers of the mouth, throat, oesophagus, liver, breast and bowel.
- Excess body weight: linked to breast (after menopause), colorectal, pancreatic, liver and several other cancers.
- Poor diet: high intake of processed meat, low fibre, low fruit and vegetable consumption can raise cancer risk.
- Physical inactivity: regular movement helps regulate hormones and weight, lowering risk for several tumour types.
The RKI’s figures align with international findings from organisations such as the American Cancer Society, which estimates that about 40% of cancers in US adults over 30 are related to potentially avoidable risk factors.
World Cancer Day puts pressure on prevention
The RKI released its latest data ahead of World Cancer Day on 4 February, a global awareness day that focuses attention on prevention, early diagnosis and treatment quality.
Public health experts argue that the numbers should act as a wake-up call for policy-makers. Greater investment in prevention campaigns, smoking cessation support, alcohol control policies and nutrition education could significantly reduce future case numbers.
Preventing cancer does not rely on one big change, but on many small, sustained shifts in individual and collective behaviour.
What these figures mean for an individual
For a person reading these statistics, the sheer scale can feel abstract. One way to think about it is through a simple scenario. Imagine a group of ten German men sitting in a waiting room: RKI data suggest roughly five of them will develop cancer during their lifetime. Among ten women, about four will face the disease.
That does not mean people are powerless. Someone who never smokes, drinks only modestly, keeps a stable weight, eats plenty of fibre, and stays physically active can lower their risk substantially, even if family history is unfavourable.
| Factor | Change | Likely effect on cancer risk |
|---|---|---|
| Smoking | Quit after long-term use | Risk of lung and other cancers drops over years, though not to zero |
| Alcohol | Reduce to low or no intake | Lower risk of liver, breast and digestive system cancers |
| Body weight | Lose excess weight gradually | Reduced risk for several hormone-related and digestive cancers |
| Screening | Take up age-appropriate tests | Greater chance of catching tumours at early, treatable stages |
Clarifying key terms: incidence, mortality and risk
Cancer reports often use jargon that can confuse readers. Three terms come up repeatedly in the RKI data.
Incidence refers to the number of new cancer cases diagnosed in a given period, usually a year. The 517,800 figure for 2023 is an incidence number. It does not say how many people already live with cancer, only how many received a new diagnosis.
Mortality means the number of deaths caused by cancer in the same period. The roughly 229,000 cancer deaths in 2023 are a mortality figure. Falling mortality can occur even when incidence rises, if treatments improve and more cancers are cured or controlled for longer.
Lifetime risk describes the probability of a person developing cancer at any point during their life. When the RKI cites 49% for men and 43% for women, it is talking about this lifetime risk, not about a short-term threat.
A long-term shift in health priorities
As Germany’s population ages and lifestyle-related risks persist, cancer will remain a central challenge for the health system. At the same time, research is advancing, from personalised therapies to better screening tools.
For individuals, the message behind the statistics is twofold: no one can fully rule out cancer, but daily choices around tobacco, alcohol, food, exercise and screening can tilt the odds. On a national scale, the RKI numbers suggest that even modest improvements across millions of people could prevent tens of thousands of diagnoses in the coming decades.
